Rat issue resolved...check, efficiency per Coleman we meet the minimum requirement....check, no heart valve problems.... check, studies are complete and submitted...check, per FDA request drug was tested as a stand alone appetite suppresent....check, Additional patents submitted.....check, manufacturing facility ready to go.....check, European application submitted.......check, Side effects almost none.....check, WHAT AM I MISSING?...Is there some anything anyone can say other than at this price give me some more shares!
still...only threats. Its all about corruption as to ARNA not getting a positive result from the FDA. Thats all anybody has to offer. The issue is under a microscope & a lot of money & time has been spent with positive legitiment results. At this point the shorts don't even have a counterpoint. If you have something to offer say it .... I'm telling you no counterpoint.
Really, nobody is closer to the data than the companies who conducted the clinical trials. If a drug is brought to market, nobody has more to lose than those companies in the event of serious shortcomings.
Arena is a small company that would disappear in such an event. Eisai is a very large and reputable company and even the possibility of a blockbuster drug would not induce them to risk their business on a drug they did not believe in.
If both Arena and especially Eisai want to bring the market, they more than confident in the drugs safety. It is simply not worth it for them to play games.